This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 May 2;368(18):1665-8.

doi: 10.1056/NEJMp1302726.

Cardiovascular risks with azithromycin and other antibacterial drugs

Andrew D Mosholder¹, Justin Mathew, John J Alexander, Harry Smith, Sumathi Nambiar

Affiliations

Affiliation

¹ Office of Surveillance and Epidemiology, Division of Epidemiology II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

PMID: 23635046
DOI: 10.1056/NEJMp1302726

Free article

Comment

Cardiovascular risks with azithromycin and other antibacterial drugs

Andrew D Mosholder et al. N Engl J Med. 2013.

Free article

. 2013 May 2;368(18):1665-8.

doi: 10.1056/NEJMp1302726.

Authors

Andrew D Mosholder¹, Justin Mathew, John J Alexander, Harry Smith, Sumathi Nambiar

Affiliation

¹ Office of Surveillance and Epidemiology, Division of Epidemiology II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

PMID: 23635046
DOI: 10.1056/NEJMp1302726

No abstract available

PubMed Disclaimer

Comment in

Cardiovascular risks with azithromycin.
McMurray JJ, Jhund PS. McMurray JJ, et al. N Engl J Med. 2013 Aug 8;369(6):579-80. doi: 10.1056/NEJMc1306999. N Engl J Med. 2013. PMID: 23924017 No abstract available.
Cardiovascular risks with azithromycin.
Brass EP. Brass EP. N Engl J Med. 2013 Aug 8;369(6):580. doi: 10.1056/NEJMc1306999. N Engl J Med. 2013. PMID: 23924018 No abstract available.
Cardiovascular risks with azithromycin.
Mosholder AD, Nambiar S. Mosholder AD, et al. N Engl J Med. 2013 Aug 8;369(6):581. doi: 10.1056/NEJMc1306999. N Engl J Med. 2013. PMID: 23930274 No abstract available.

Comment on

Azithromycin and the risk of cardiovascular death.
Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Ray WA, et al. N Engl J Med. 2012 May 17;366(20):1881-90. doi: 10.1056/NEJMoa1003833. N Engl J Med. 2012. PMID: 22591294 Free PMC article.
Use of azithromycin and death from cardiovascular causes.
Svanström H, Pasternak B, Hviid A. Svanström H, et al. N Engl J Med. 2013 May 2;368(18):1704-12. doi: 10.1056/NEJMoa1300799. N Engl J Med. 2013. PMID: 23635050

Similar articles

Cardiovascular risks with azithromycin.
Mosholder AD, Nambiar S. Mosholder AD, et al. N Engl J Med. 2013 Aug 8;369(6):581. doi: 10.1056/NEJMc1306999. N Engl J Med. 2013. PMID: 23930274 No abstract available.
Cardiovascular risks with azithromycin.
Brass EP. Brass EP. N Engl J Med. 2013 Aug 8;369(6):580. doi: 10.1056/NEJMc1306999. N Engl J Med. 2013. PMID: 23924018 No abstract available.
Cardiovascular risks with azithromycin.
McMurray JJ, Jhund PS. McMurray JJ, et al. N Engl J Med. 2013 Aug 8;369(6):579-80. doi: 10.1056/NEJMc1306999. N Engl J Med. 2013. PMID: 23924017 No abstract available.
Azithromycin associated with a small increased risk of cardiovascular death: a review.
Wynn RL. Wynn RL. Gen Dent. 2013 Mar-Apr;61(2):8-9. Gen Dent. 2013. PMID: 23454312 Review. No abstract available.
Azithromycin and the risk of cardiovascular complications.
Maisch NM, Kochupurackal JG, Sin J. Maisch NM, et al. J Pharm Pract. 2014 Oct;27(5):496-500. doi: 10.1177/0897190013516503. J Pharm Pract. 2014. PMID: 25374989 Review.

See all similar articles

Cited by

A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study.
Meyer Sauteur PM, Seiler M, Tilen R, Osuna E, von Wantoch M, Sidorov S, Aebi C, Agyeman P, Barbey F, Bielicki JA, Coulon L, Deubzer B, Donas A, Heininger U, Keitel K, Köhler H, Kottanattu L, Lauener R, Niederer-Loher A, Posfay-Barbe KM, Tomaske M, Wagner N, Zimmermann P, Zucol F, von Felten S, Berger C. Meyer Sauteur PM, et al. Trials. 2024 Oct 3;25(1):655. doi: 10.1186/s13063-024-08438-6. Trials. 2024. PMID: 39363201 Free PMC article.
Plasmid-mediated azithromycin resistance in non-typhoidal Salmonella recovered from human infections.
Zhang XW, Song JJ, Zeng SH, Huang YL, Luo JJ, Guo WL, Li XY. Zhang XW, et al. J Antimicrob Chemother. 2024 Oct 1;79(10):2688-2697. doi: 10.1093/jac/dkae281. J Antimicrob Chemother. 2024. PMID: 39119898 Free PMC article.
Still Looking for a Simple, Effective Prevention Measure for Neonatal Sepsis in High-Mortality Settings.
Schrag SJ, Whitney CG. Schrag SJ, et al. JAMA. 2023 Mar 7;329(9):711-712. doi: 10.1001/jama.2022.24139. JAMA. 2023. PMID: 36881044 Free PMC article. No abstract available.
Treating asthma in the time of COVID.
Carr TF, Fajt ML, Kraft M, Phipatanakul W, Szefler SJ, Zeki AA, Peden DB, White SR; Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Research Group. Carr TF, et al. J Allergy Clin Immunol. 2023 Apr;151(4):809-817. doi: 10.1016/j.jaci.2022.12.800. Epub 2022 Dec 14. J Allergy Clin Immunol. 2023. PMID: 36528110 Free PMC article.
Mechanism of action, resistance, synergism, and clinical implications of azithromycin.
Heidary M, Ebrahimi Samangani A, Kargari A, Kiani Nejad A, Yashmi I, Motahar M, Taki E, Khoshnood S. Heidary M, et al. J Clin Lab Anal. 2022 Jun;36(6):e24427. doi: 10.1002/jcla.24427. Epub 2022 Apr 21. J Clin Lab Anal. 2022. PMID: 35447019 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- H1 Connect
- scite Smart Citations
Medical
- MedlinePlus Health Information